Status:

RECRUITING

Atrial Anomalies Predict Silent Atrial Fibrillation Detected by Implantable Cardiac Monitor in Cryptogenic Stroke

Lead Sponsor:

Parc de Salut Mar

Conditions:

Paroxysmal Atrial Fibrillation

Cardiac Rhythm Disorder

Eligibility:

All Genders

50-89 years

Phase:

NA

Brief Summary

Cryptogenic stroke (CS) causes about 30% of admissions to a stroke unit. Silent paroxysmal atrial fibrillation (PAF) is believed to be the underlying cause of a significant proportion of patients. The...

Detailed Description

Introduction Cryptogenic stroke (CS) is a stroke in which etiology cannot be determined after a comprehensive evaluation and it is the cause of about 30% of admissions to a stroke unit. In these case...

Eligibility Criteria

Inclusion

  • Acute ischemic stroke or transient ischemic attack (TIA) from January 2022 to July 2023
  • Age between 50 and 89 years;
  • Undetermined origin at hospital admission according to the SSS-TOAST criteria (2):
  • Absence of major structural heart disease by cardiac ultrasound (normal global and segmental left ventricle contraction, absence of valvular/rheumatic disease, absence of intracardiac shunts)
  • Absence of AF during 48h ECG-monitoring
  • Absence of major anomalies in the supra-aortic trunks ultrasound.

Exclusion

  • Patients with a history of hemorrhagic stroke;
  • Presence with prior atrial fibrillation or atrial flutter;
  • Permanent contraindication or indication for OAC for other reasons;
  • Recent (\<1 month) major surgery or cardiac events;
  • Presence of severe cardiac abnormalities;
  • Patients with life expectancy \<1 year or severe stroke (modified Rankin Scale \> 4).

Key Trial Info

Start Date :

January 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2024

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT06542770

Start Date

January 1 2021

End Date

December 1 2024

Last Update

August 7 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital del Mar

Barcelona, Spain, 08003